EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 225 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2016. The put-call ratio across all filers is 4.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,125,000 | -73.1% | 35,700 | -76.0% | 0.09% | -76.7% |
| Q2 2016 | $4,184,000 | +22.5% | 148,800 | +58.3% | 0.39% | +13.3% |
| Q1 2016 | $3,416,000 | -9.1% | 94,000 | 0.0% | 0.34% | -28.0% |
| Q4 2015 | $3,760,000 | +31.3% | 94,000 | -6.5% | 0.48% | +28.8% |
| Q3 2015 | $2,863,000 | -13.5% | 100,500 | 0.0% | 0.37% | -19.7% |
| Q2 2015 | $3,311,000 | +128.0% | 100,500 | +99.0% | 0.46% | +128.1% |
| Q1 2015 | $1,452,000 | +68.8% | 50,500 | +59.8% | 0.20% | +40.0% |
| Q4 2014 | $860,000 | +27.8% | 31,600 | 0.0% | 0.14% | +43.6% |
| Q3 2014 | $673,000 | -58.7% | 31,600 | -56.5% | 0.10% | -58.3% |
| Q2 2014 | $1,630,000 | -49.8% | 72,600 | -43.5% | 0.24% | -52.1% |
| Q1 2014 | $3,247,000 | +110.8% | 128,500 | +91.8% | 0.50% | +89.1% |
| Q4 2013 | $1,540,000 | +57.9% | 67,000 | +30.9% | 0.27% | +19.7% |
| Q3 2013 | $975,000 | +11.7% | 51,200 | -15.5% | 0.22% | -4.7% |
| Q2 2013 | $873,000 | – | 60,600 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
| Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
| SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
| Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
| Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
| BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
| EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
| DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |